Living related liver transplantation in patients with ABO incompatibility.
Takayama
J
J
Second Department of Surgery, Tohoku University, School of Medicine, Sendai, Japan.
Ohkohchi
N
N
Oikawa
K
K
Asakura
T
T
Kawagishi
N
N
Kikuchi
H
H
Koyamada
N
N
Orii
T
T
Sakurada
M
M
Doi
H
H
Fujimori
K
K
Katoh
H
H
Satake
M
M
Satomi
S
S
D000017:ABO Blood-Group System; D001656:Biliary Atresia / Q000601:surgery; D001787:Blood Group Incompatibility; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D010290:Parents; D010951:Plasma Exchange; D010956:Plasmapheresis; D016559:Tacrolimus / Q000627:therapeutic use
D000017:ABO Blood-Group System; D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; C037258:gusperimus; D016559:Tacrolimus